- Home
- IMNM vs CCSI Comparison
IMNM vs CCSI Comparison
Compare IMNM & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- CCSI
- Stock Information
- Founded
- IMNM 2006
- CCSI 2021
- Country
- IMNM United States
- CCSI United States
- Employees
- IMNM N/A
- CCSI N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- CCSI Retail: Computer Software & Peripheral Equipment
- Sector
- IMNM Health Care
- CCSI Technology
- Exchange
- IMNM Nasdaq
- CCSI Nasdaq
- Market Cap
- IMNM 542.6M
- CCSI 475.1M
- IPO Year
- IMNM 2020
- CCSI N/A
- Fundamental
- Price
- IMNM $7.91
- CCSI $18.78
- Analyst Decision
- IMNM Strong Buy
- CCSI Hold
- Analyst Count
- IMNM 6
- CCSI 5
- Target Price
- IMNM $26.00
- CCSI $27.20
- AVG Volume (30 Days)
- IMNM 1.7M
- CCSI 157.1K
- Earning Date
- IMNM 05-13-2025
- CCSI 05-07-2025
- Dividend Yield
- IMNM N/A
- CCSI N/A
- EPS Growth
- IMNM N/A
- CCSI 17.26
- EPS
- IMNM N/A
- CCSI 4.62
- Revenue
- IMNM $9,041,000.00
- CCSI $350,382,000.00
- Revenue This Year
- IMNM N/A
- CCSI $1.26
- Revenue Next Year
- IMNM $1,259.12
- CCSI $0.88
- P/E Ratio
- IMNM N/A
- CCSI $4.06
- Revenue Growth
- IMNM N/A
- CCSI N/A
- 52 Week Low
- IMNM $5.15
- CCSI $11.62
- 52 Week High
- IMNM $19.07
- CCSI $32.10
- Technical
- Relative Strength Index (RSI)
- IMNM 55.28
- CCSI 30.54
- Support Level
- IMNM $6.96
- CCSI $18.34
- Resistance Level
- IMNM $7.56
- CCSI $20.00
- Average True Range (ATR)
- IMNM 0.69
- CCSI 1.27
- MACD
- IMNM 0.26
- CCSI -0.18
- Stochastic Oscillator
- IMNM 98.22
- CCSI 8.33
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.